| Mast cell activation and autism. | |
| | |
MedLine Citation:
|
PMID: 21193035 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
Autism spectrum disorders (ASD) are neurodevelopmental disorders characterized by varying degrees of dysfunctional communication and social interactions, repetitive and stereotypic behaviors, as well as learning and sensory deficits. Despite the impressive rise in the prevalence of autism during the last two decades, there are few if any clues for its pathogenesis, early detection or treatment. Increasing evidence indicates high brain expression of pro-inflammatory cytokines and the presence of circulating antibodies against brain proteins. A number of papers, mostly based on parental reporting on their children's health problems, suggest that ASD children may present with "allergic-like" problems in the absence of elevated serum IgE and chronic urticaria. These findings suggest non-allergic mast cell activation, probably in response to environmental and stress triggers that could contribute to inflammation. In utero inflammation can lead to preterm labor and has itself been strongly associated with adverse neurodevelopmental outcomes. Premature babies have about four times higher risk of developing ASD and are also more vulnerable to infections, while delayed development of their gut-blood-brain barriers makes exposure to potential neurotoxins likely. Perinatal mast cell activation by infectious, stress-related, environmental or allergic triggers can lead to release of pro-inflammatory and neurotoxic molecules, thus contributing to brain inflammation and ASD pathogenesis, at least in a subgroup of ASD patients. This article is part of a Special Issue entitled: Mast cells in inflammation. |
| | |
Authors:
|
Theoharis C Theoharides; Asimenia Angelidou; Konstantinos-Dionysios Alysandratos; Bodi Zhang; Shahrzad Asadi; Konstantinos Francis; Elena Toniato; Dimitrios Kalogeromitros |
Related Documents
:
|
11600175 - Cytokine cross-talk between mother and the embryo/placenta. 19535235 - Angiostatic versus angiogenic chemokines in ipf and eaa. 16570855 - Cytokine and chemokine networks: pathways to antiviral defense. 16005185 - Diverse signaling pathways through the sdf-1/cxcr4 chemokine axis in prostate cancer ce... 980285 - Cell-mediated immunity and blocking factor in ovarian carcinoma. 8733295 - Apoptosis is induced in the subependyma of young adult rats by ionizing irradiation. |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2010-12-28 |
Journal Detail:
|
Title: Biochimica et biophysica acta Volume: - ISSN: 0006-3002 ISO Abbreviation: - Publication Date: 2010 Dec |
Date Detail:
|
Created Date: 2011-1-28 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0217513 Medline TA: Biochim Biophys Acta Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Copyright Information:
|
Copyright © 2010. Published by Elsevier B.V. |
Affiliation:
|
Molecular Immunopharmacology and Drug Discovery Laboratory, Department of Pharmacology and Experimental Therapeutics, Tufts University School of Medicine, Boston, MA 02111, USA; Department of Biochemistry, Tufts University School of Medicine, Boston, MA 02111, USA; Department of Internal Medicine, Tufts University School of Medicine and Tufts Medical Center, Boston, MA 02111, USA; Department of Psychiatry, Tufts University School of Medicine and Tufts Medical Center, Boston, MA 02111, USA; Allergy Clinical Research Center, Allergy Section, Attikon General Hospital, University of Athens Medical School, Athens 12462, Greece. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Role of nuclear receptor corepressor RIP140 in metabolic syndrome.
Next Document: The development of a whole-cell based medium throughput screening system for the discovery of human ...